This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
RenaissanceRe (RNR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
RenaissanceRe (RNR) delivered earnings and revenue surprises of 29.66% and 3.68%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RenaissanceRe (RNR) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Get a deeper insight into the potential performance of RenaissanceRe (RNR) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Analysts Estimate HCI Group (HCI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCI Group (HCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RenaissanceRe (RNR) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
RenaissanceRe (RNR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Erie Indemnity Set to Report Q3 Earnings: What to Expect
by Zacks Equity Research
ERIE's third-quarter results are likely to benefit from improved performance at both the personal and commercial lines.
Is a Beat in Store for Everest Group This Earnings Season?
by Zacks Equity Research
EG's third-quarter results are likely to reflect higher premiums, driven by rate and exposure increases, across both segments.
Why RenaissanceRe (RNR) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should AXS Stock Be in Your Portfolio Ahead of Q3 Earnings?
by Tanuka De
Axis Capital's third-quarter results are likely to gain from solid performance at both the segments.
Is First Trust Growth Strength ETF (FTGS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FTGS
Will RenaissanceRe (RNR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AXS Stock Trades at a Discount to Industry: Should You Buy or Hold?
by Tanuka De
Axis Capital continues to build on specialty insurance, reinsurance as well as the accident and health portfolio.
Should First Trust Growth Strength ETF (FTGS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTGS
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
RenaissanceRe (RNR) Soars 3.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
RenaissanceRe (RNR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RenaissanceRe (RNR) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
RenaissanceRe Adds Nearly $4B in Market Cap in 2024: Still a Buy?
by Zacks Equity Research
Despite being at its peak, RNR remains a compelling buy due to its solid cash position, favorable valuation and upward trend in earnings estimates.
RenaissanceRe Holdings Ltd. (RNR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
RenaissanceRe (RNR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
RNR vs. CB: Which Stock Is the Better Value Option?
by Zacks Equity Research
RNR vs. CB: Which Stock Is the Better Value Option?
Is ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for REGL
Here's Why RenaissanceRe (RNR) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AXS Stock Near 52-Week High: Should You Buy or Wait for a Pullback?
by Tanuka De
Axis Capital continues to build on specialty insurance, reinsurance, as well as the accident and health portfolio.
Here's Why RenaissanceRe (RNR) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RenaissanceRe Stock Near 52-Week High: Time to Lock in Gains?
by Zacks Equity Research
RNR's strong cash position supports its growth initiatives and shareholder returns.